Review Note

Last Update: 02/08/2025 09:55 PM

Current Deck: Pharm Cardio Exam 1

Published

Currently Published Content


Front
valsartan
Back
Class: ANG II receptor blockers (ARBs)
Subclass: -rtan
MOA: block the ANG II receptor so action of ANG II is inhibited; decrease action of ANG II
AE: cough, angioedema, may reduce progression of type 2 diabetic nephropathy
Indication: don't help with bradykinen remodeling; given if ACE inhibitor cannot be tolerated
CI: pregnancy
Route: 

No published tags.

Pending Suggestions


No pending suggestions for this note.